Q2 2021 Holdings
Filed 2021-08-12 | 262 holdings | $1.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $293.3M | 974,038 | 15.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $262.6M | 1,549,092 | 13.8% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $239.9M | 4,352,992 | 12.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $182.9M | 528,100 | 9.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $172.3M | 2,237,403 | 9.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $101.1M | 1,386,297 | 5.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $99.5M | 2,326,787 | 5.2% |
| Align Technology Inc(ALGN) | COM | 016255101 | $95.8M | 156,770 | 5.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $78.9M | 612,821 | 4.1% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $65.9M | 178,270 | 3.5% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $56.2M | 87,301 | 3.0% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $42.2M | 3,463,000 | 2.2% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $39.3M | 962,352 | 2.1% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $36.5M | 324,200 | 1.9% |
| Atricure Inc(ATRC) | COM | 04963C209 | $29.7M | 374,418 | 1.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $28.9M | 84,300 | 1.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $23.7M | 352,021 | 1.2% |
| Avantor Inc(AVTR) | COM | 05352A100 | $18.2M | 512,216 | 1.0% |
| Caredx Inc(CDNA) | COM | 14167L103 | $13.6M | 148,871 | 0.7% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $5.1M | 22,600 | 0.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $3.4M | 40,500 | 0.2% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $2.1M | 75,000 | 0.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.6M | 65,900 | 0.1% |
| Cellectis S A(CLLS) | SPON ADS | 15117K103 | $1.3M | 83,500 | 0.1% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $1.2M | 31,000 | 0.1% |
| Moderna Inc(MRNA) | COM | 60770K107 | $597.4K | 2,542,300 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $396.1K | 9,930,245 | 0.0% |
| Carmax Inc(KMX) | COM | 143130102 | $368.0K | 2,850 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $349.6K | 1,733,694 | 0.0% |
| Constellation Brands Inc(STZ) | CL A | 21036P108 | $341.0K | 1,459 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $293.7K | 3,017,751 | 0.0% |
| Costar Group Inc(CSGP) | COM | 22160N109 | $290.0K | 3,500 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $250.0K | 2,971,400 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $226.8K | 2,613,536 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $198.1K | 7,376,026 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $185.9K | 202,095 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $177.9K | 465,976 | 0.0% |
| Abbott Labs(ABT) | COM | 002824100 | $159.7K | 1,377,499 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $156.5K | 966,884 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $147.4K | 3,609,919 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $137.4K | 7,531,414 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $137.4K | 343,051 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $134.3K | 2,364,204 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $129.6K | 482,940 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $125.2K | 282,755 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $120.0K | 5,269,039 | 0.0% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $112.1K | 460,965 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $109.7K | 1,730,471 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $104.5K | 244,776 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $101.0K | 2,224,466 | 0.0% |